Clinical trials generate large amounts of data. However, collecting data is only one part of the process. The real value comes from analysing that data correctly and drawing reliable conclusions from it.  This is where clinical biostatistics services play an important role.  Biostatisticians help research teams plan the right analytical approach, reduce bias, check data quality, and apply suitable statistical methods. […]

Running a clinical trial in more than one country can help sponsors reach a wider patient population and collect data from different markets. However, it also makes the regulatory process more complex.  Each country may follow its own rules, review procedures, document requirements, and ethics approval process. A regulatory submission that is accepted in one market may […]

How proactive safety oversight protects participants, strengthens data integrity, and supports successful clinical development  Clinical research is built on a commitment—to advance medical science while safeguarding the individuals who make that progress possible. Every participant who enrolls in a clinical trial places trust in the research team, sponsor, and broader clinical development ecosystem. Clinical safety is how that trust is upheld every […]

For any pharmaceutical company planning to run a clinical trial in India, the approval process from the Central Drugs Standard Control Organisation (CDSCO) is often the first major hurdle. Delays at this stage can push back study start dates by months, increase costs, and put entire development timelines at risk. This is one of the […]

Your Ingredient May Be Clinically Proven… But Is Your Product?  The nutraceutical industry is evolving rapidly. Consumers today are more informed, healthcare professionals are asking tougher questions, and brands are competing in an increasingly crowded marketplace. In this environment, simply stating that an ingredient is “clinically proven” is no longer enough.  One of the most common approaches adopted by […]

Medical devices do not stop being monitored once they reach the market. Regulators require companies to keep tracking how a device performs after it is sold and used by real patients. This process is called post-market surveillance, or PMS. It involves collecting safety data, writing reports, and updating regulators on any risks that appear over time.  This is where medical […]

Consumer Perception Studies: The Missing Link Between Science and Market Success  The Indian nutraceutical industry is growing rapidly, with new products entering the market almost every day. While companies invest significantly in research, formulation, and clinical validation, one critical aspect is often overlooked—how consumers actually perceive the product.  A product may have excellent scientific evidence, but if […]

Patient recruitment is one of the biggest challenges in clinical trials. According to NIH, nearly 80% of trials fail to meet their enrolment deadlines. This delay pushes back drug approvals, increases costs, and ultimately slows down access to life-saving treatments.  However, in 2026, things are changing. A growing number of sponsors are turning to a clinical research organisation in India to speed up recruitment without compromising data quality […]

A Clinical Study Report (CSR) is one of the most important documents in drug development. It summarises the results of a clinical trial for regulatory agencies like the FDA and EMA.  Getting it right matters. Even minor errors can trigger lengthy reviewer queries. In serious cases, they can lead to rejection or a Complete Response […]

The demand for clinical trial services is growing fast. According to MarketsandMarkets, the global clinical trial services market was valued at $60.76 billion in 2024 and is expected to reach $101.86 billion by 2030. With so many CROs competing for your business, it is easy to feel overwhelmed during the selection process.  An experienced CRO can complete the trail in given time […]